Panacea Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $143.75M
IPO Date Jul 1, 2020
CEO Oleg Nodelman
Left Lead Cowen
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology

IPO Geography Global
Target Company Nuvation Bio
Deal Announced Oct 21, 2020
Deal Size, $M $1,319.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Feb 9, 2021
Amendment Vote TBD
Closing Date Feb 10, 2021
Formerly PANA NUVB NUVB/W

Sign up for Free Trial

No credit card required

Sign in for more on Panacea Acquisition Corp.:

  • Structure and cap table
  • 9 directors & officers
  • 18 filings and events
  • 1 underwriters
  • 6 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Oleg Nodelman 43 CEO and Chairman
Scott Perlen 45 CFO
Scott Platshon 28 COO
Caroline Stout 29 Secretary and Director
Sarah Marriott 43 Director
Daniel Bradbury 59 Director
Graham Cooper 50 Director
Faheem Hasnain 62 Director
Shalini Sharp 45 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cowen BR 12,500,000 units
12,500,000 units
Up-Front UW fee 2.00 %
BCMA 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 18 filings.

Shareholders

Sign in to view shareholders 13F filing data.